Category: Medications - Page 2

By Teddy Rankin, 26 Jan, 2026 / Medications

Psychiatric Medications: Class Interactions and Dangerous Combinations

Psychiatric medication interactions can be life-threatening. Learn the most dangerous combinations like MAOIs with SSRIs, lithium with NSAIDs, and why some drugs are safer to combine. Know the signs, monitoring rules, and what to do now.

By Teddy Rankin, 18 Jan, 2026 / Medications

Bariatric Surgery and Medication Absorption: How Weight Loss Surgery Changes Your Drug Doses

Bariatric surgery changes how your body absorbs medications. Levothyroxine, warfarin, and extended-release drugs often fail after gastric bypass or sleeve gastrectomy. Learn what to do before and after surgery to stay safe.

By Teddy Rankin, 16 Jan, 2026 / Medications

NSAIDs and Kidney Disease: How to Prevent Acute Kidney Injury

NSAIDs like ibuprofen and naproxen can cause sudden kidney damage, especially in people with existing kidney disease. Learn how to avoid acute kidney injury with simple, science-backed steps.

By Teddy Rankin, 15 Jan, 2026 / Medications

Cost Barriers to Medication Adherence and How to Get Help

Cost barriers prevent millions from taking prescribed medications, leading to serious health risks. Learn why people skip doses, who’s most affected, and how to access affordable options-from patient programs to GoodRx and Medicare help.

By Teddy Rankin, 14 Jan, 2026 / Medications

FDA Boxed Warnings Explained: What You Need to Know Before Taking High-Risk Medications

FDA boxed warnings, or black box warnings, are the strongest safety alerts for prescription drugs. Learn what they mean, which drugs carry them, and how to stay safe when taking high-risk medications.

By Teddy Rankin, 13 Jan, 2026 / Medications

Hatch-Waxman Act: How Federal Law Shapes Generic Drug Approval

The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation and affordability. It enabled 90% of prescriptions to be filled with generics, saving $158 billion annually.

By Teddy Rankin, 12 Jan, 2026 / Medications

ADHD Stimulants and MAOIs: What You Need to Know About Hypertensive Crisis Risks

Combining ADHD stimulants with MAOIs can cause a dangerous hypertensive crisis. Learn why this interaction is life-threatening, which medications carry the highest risk, and what safer alternatives exist.

By Teddy Rankin, 8 Jan, 2026 / Medications

How the FDA Monitors Generic Drug Safety After Approval

The FDA doesn't test every generic drug after approval, but it has a robust system to monitor safety through real-world reports, manufacturing data, and patient feedback. Here's how they catch problems and protect public health.

By Teddy Rankin, 7 Jan, 2026 / Medications

How to Identify and Report Elderly Medication Mistakes

Learn how to spot, document, and report medication mistakes in elderly loved ones. From wrong doses to dangerous drug interactions, this guide gives you clear steps to protect seniors and hold facilities accountable.

By Teddy Rankin, 4 Jan, 2026 / Medications

Opioids in Seniors: Safe Pain Management and Monitoring Practices

Safe opioid use for seniors requires low starting doses, careful monitoring, and avoiding dangerous drugs like meperidine and codeine. Buprenorphine and immediate-release options are preferred. Non-opioid alternatives and functional goals are key.

By Teddy Rankin, 31 Dec, 2025 / Medications

Migraine Medications: Triptans, Gepants, and Ditans Safety Compared

Triptans, gepants, and ditans are the three main acute migraine medications. Each has different safety profiles: triptans carry cardiovascular risks, ditans cause sedation, and gepants offer the cleanest side effect profile. Learn which is safest for your needs.

By Teddy Rankin, 30 Dec, 2025 / Medications

Generic Drug Supply Chain: How Medicines Reach Pharmacies

Generic drugs make up 90% of U.S. prescriptions but cost just 23% of total drug spending. This article breaks down how these medicines travel from overseas factories to your pharmacy-and why the system is under strain.